This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chakraborty, G. Articles by Kundu, G. C. Search for Related Content PubMed PubMed Citation Articles by Chakraborty, G. Articles by Kundu, G. C.

Osteopontin Promotes Vascular Endothelial Growth Factor–Dependent Breast Tumor Growth and Angiogenesis via Autocrine and Paracrine Mechanisms

National Center for Cell Science, Pune, India

Requests for reprints: Gopal C. Kundu, National Center for Cell Science, Pune 411 007, India. Phone: 91-20-25708103; Fax: 91-20-25692259; E-mail: kundu{at}nccs.res.in.

Angiogenesis is the hallmark of cancer, and development of aggressiveness of primary tumor depends on de novo angiogenesis. Here, using multiple in vitro and in vivo models, we report that osteopontin (OPN) triggers vascular endothelial growth factor (VEGF)–dependent tumor progression and angiogenesis by activating breast tumor kinase (Brk)/nuclear factor–inducing kinase/nuclear factor-B (NF-B)/activating transcription factor-4 (ATF-4) signaling cascades through autocrine and paracrine mechanisms in breast cancer system. Our results revealed that both exogenous and tumor-derived OPN play significant roles in VEGF-dependent tumor angiogenesis. Clinical specimen analysis showed that OPN and VEGF expressions correlate with levels of neuropilin-1, Brk, NF-B, and ATF-4 in different grades of breast cancer. Consequently, OPN plays essential role in two key aspects of tumor progression: VEGF expression by tumor cells and VEGF-stimulated neovascularization. Thus, targeting OPN and its regulated signaling network could be a novel strategy to block tumor angiogenesis and may develop an effective therapeutic approach for the management of breast cancer. [Cancer Res 2008;68(1):152–61]

This article has been cited by other articles:

				X. Tong, K. Li, Z. Luo, B. Lu, X. Liu, T. Wang, M. Pang, B. Liang, M. Tan, M. Wu, et al. Decreased TIP30 Expression Promotes Tumor Metastasis in Lung Cancer Am. J. Pathol., May 1, 2009; 174(5): 1931 - 1939. [Abstract] [Full Text] [PDF]

				S. F. Abcouwer and C. N. Roybal Regulation of Vascular Endothelial Growth Factor A by Activating Transcription Factor 4 Circ. Res., October 24, 2008; 103(9): e118 - e118. [Full Text] [PDF]

				L. M. Khachigian, A. Bobik, P. Kanellakis, and K. Malabanan Response to Abcouwer and Roybal Circ. Res., October 24, 2008; 103(9): e119 - e119. [Full Text] [PDF]

				K. P. Malabanan, P. Kanellakis, A. Bobik, and L. M. Khachigian Activation Transcription Factor-4 Induced by Fibroblast Growth Factor-2 Regulates Vascular Endothelial Growth Factor-A Transcription in Vascular Smooth Muscle Cells and Mediates Intimal Thickening in Rat Arteries Following Balloon Injury Circ. Res., August 15, 2008; 103(4): 378 - 387. [Abstract] [Full Text] [PDF]